Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Seminars in Oncology|December 1, 1992
The National Cancer Institute: cancer drug discovery and development programM R Grever, S A Schepartz, B A ChabnerJournal of Natural Products|October 1, 1993
The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agentsG M Cragg, S A Schepartz, M Suffness, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Historical overview of the National Cancer Institute Fermentation ProgramS A SchepartzThe Japanese Journal of Antibiotics|December 1, 1977
Antitumor screening procedures of the National Cancer InstituteS A SchepartzNouvelle Revue Francaise D'Hematologie|January 1, 1986
Progress and perspectives of systemic anticancer treatmentB A Chabner, E ReedThe Journal of Clinical Investigation|September 1, 1983
Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductaseJ Jolivet, B A ChabnerSeminars in Oncology|July 6, 2000
Pentostatin (Nipent): a review of potential toxicity and its managementJ Margolis, M R GreverClinical Chemistry|August 1, 1996
Concepts in use of high-dose methotrexate therapyS P Treon, B A ChabnerThe Journal of Clinical Investigation|August 1, 1973
Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissuesB A Chabner, R C YoungPageof 21